Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
Status:
Completed
Trial end date:
2022-05-30
Target enrollment:
Participant gender:
Summary
To compare the abv3-integrin expression in endometrium tissue among RIF women between the
GnRH analogue with Aromatase Inhibitor (Group A) , GnRH analogue with progesterone (Group B)
and GnRH analogue alone as control group (Group C)